过氧化体增殖物激活型受体基因变异与代谢综合征的相关性
被引量:2
摘要
过氧化体增殖物激活型受体的活性与代谢综合征的各个组分密切相关。而过氧化体增殖物激活型受体基因变异可能导致代谢综合征的发生。过氧化体增殖物激活型受体α、γ、δ三个亚型的基因多态性与胰岛素抵抗、2型糖尿病、混合型高脂血症及肥胖密切相关。本文综述了相关文献资料,以期加强对过氧化体增殖物激活型受体基因多态性的认识,指导代谢综合征基因变异方面的基础理论研究。
出处
《中国动脉硬化杂志》
CAS
CSCD
2007年第1期74-76,共3页
Chinese Journal of Arteriosclerosis
参考文献35
-
1Gurnell M,Savage DB,Chatterjee VK,O'Rahilly S.The metabolic syndrome:peroxisome proliferator-activated receptor gamma and its therapeutic modulation[J].J Clin Endocrinol Metab,2003,88:2 412-421.
-
2Meirhaeghe A,Amouyel P.Impact of genetic variation of PPAR gamma in humans[J].Mol Genet Metab,2004,83:93-102.
-
3Miles PD,Barak Y,He W,Evans RM,Olefsky JM.Improved insulin sensitivity in mice heterozygous for PPARγ deficiency[J].J Clin Invest,2000,105:287-292.
-
4Rosen ED,Sarraf P,Troy AE,Bradwin G,Moore K,Milstone DS,et al.PPAR gamma is reguired for the differentiation of adipose tissure in vivo and invitro[J].Mol Cell,1999,4:611-617.
-
5Moon MK,Cho YM,Jung HS,Park YJ,Yoon KH,Sung YA,et al.Genetic polymorphisms in peroxisome proliferator-activated receptor gamma are associated with type 2 diabetes mellitus and obesity in the Korean population[J].Diabet Med,2005,22 (9):1 161-166.
-
6Ghoussaini M,Meyre D,Lobbens S,Charpentier G,Clement K,Charles MA,et al.Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population[J].BMC Med Genet,2005,22 (6):11.
-
7Ristow M,Muller Wieland D,Pfeiffer A,Krone W,Kahn CR.Obesity associated with a mutation in a genetic regulator of adipocyte differentiation[J].N Engl J Med,1998,339:953-959.
-
8Swarbrick MM,Chapman CM,McQuillan BM,Hung J,Thompson PL,Beilby JP.A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity[J].Eur J Endocrinol,2001,144 (3):277-282.
-
9Meirhaeghe A,Tanck MW,Fajas L,Janot C,Helbecque N,Cottel D,et al.Study of a new PPAR gamma2 promoter polymorphism and haplotype analysis in a French population[J].Mol Genet Metab,2005,85 (2):140-148.
-
10Tanko LB,Siddiq A,Lecoeur C,Larsen PJ,Christiansen C,Walley A,et al.ACDC/adiponectin and PPAR-gamma gene polymorphisms:implications for features of obesity[J].Obes Res,2005,13 (12):2 113-121.
二级参考文献31
-
1祝之明,周芳明,张刚,赵志钢,倪银星,祝善俊.代谢综合征心血管重塑的特征[J].中华心血管病杂志,2004,32(9):819-820. 被引量:41
-
2Yen CJ,Beamer BA,Negri C,et al. Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPARgamma2 missense mutation. Biochem Biophys Res Commun, 1997,241:270.
-
3Mancini FP, Vaccaro O, Sabatino L, et al.Pro12Ala substitution in the peroxisome proliferator activated receptor gamma2 is not associated with type 2 diabetes. Diabetes, 2000,49:1 466.
-
4Bluher M, Klemm T, Gerike T, et al. Lack of association between peroxisome proliferator activated receptor γ-2 gene variants and the occurrence of coronary heart disaese in patients with diabetes mellitus. European Journal of Endocrinology,2002, 146:545.
-
5Ek J, Andersen G, Urhammer SA, et al. Studies of the Pro12Ala polymorphism of the peroxisome proliferator activated receptor-γ2(PPARγ2) gene in relation to insulin sensitivity among glucose tolerant Cancasians. Diabetologia, 2001,44:1 170.
-
6Hara K, Okada T, Tobe K, et al. The Pro12Ala polymorphism in PPARγ2 may confer resistance to type 2 diabetes. Bioche Biophy Res Commun, 2000,271:212.
-
7Lee MC, Chao AH, Chen YDI, et al. Sibling-based association study of the PPARγ2 Pro12Ala polymorphism and metabolic variables in Chinese andJapanese hypertension families:a SAPPHIRe study. J Mol Med, 2001,79:656.
-
8Zietz B, Barth N, Splegel D, et al.Pro12Ala polymorphism in the peroxisome proliferator activated receptor-γ2(PPARγ2) is associated with higher levels of total cholesterol and LDL-cholesterol in male caucasian type 2 diabetes patients. Exp Clin Endocrinol Diabetes, 2002,110:60.
-
9Meirhaeghe A, Fajas L, Heibecque N, et al. Impact of the peroxisome proliferator activated receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus. Int J Obes Relat Metab Disord,2000,24:155.
-
10Mori H,Ikegami H,Kawaguchi Y,et al. The Pro12Ala substitution in PPARγ is associated with resistance to development of diabetes in the general population. Diabetes, 2001,50:891.
共引文献15
-
1杨寅卓,胡继宏,徐沛沛,于静,陈丽.过氧化物酶体增殖物激活受体γ基因多态性与动脉粥样硬化相关性的meta分析[J].慢性病学杂志,2023(2):165-174.
-
2卡丽比努尔.雅克甫,何秉贤.PPARs与血管疾病的关系[J].新疆医科大学学报,2006,29(10):1010-1011.
-
3李芹,徐济达.肥胖相关基因的多态性与肥胖的关系[J].中国学校卫生,2007,28(1):88-91. 被引量:3
-
4杨慧琴,栾姝蓉,王健,唐维德,汪传意,张静,娜青.代谢综合征与左心室肥厚关系的分析[J].心肺血管病杂志,2007,26(1):33-35. 被引量:4
-
5刘东霞,华琦,郭金成,刘力松,谭静,刘荣坤,杨峥.过氧化物酶体增生物激活受体γ基因Pro12Ala多态性与高血压的相关性研究[J].首都医科大学学报,2008,29(2):222-226. 被引量:2
-
6成建芬,齐飞波,买买提.阿不都热依木.代谢综合征心血管重构及颈动脉内-中膜厚度的临床研究[J].新疆医学,2008,38(4):68-71.
-
7常虹,叶山东.过氧化物酶体增殖物活化受体与糖脂代谢[J].中国临床保健杂志,2008,11(6):569-571. 被引量:3
-
8祝之明.代谢综合征的临床特征与发病机制[J].第三军医大学学报,2009,31(1):17-20. 被引量:52
-
9王龙飞,谈敏,常虹,余华,沈际佳.过氧化物酶体增殖物激活受体δ+294T/C基因多态性与冠心病的关系[J].安徽医科大学学报,2008,43(6):701-705. 被引量:1
-
10齐春娜,郭淑霞.PPARγ基因与代谢综合征关系的研究进展[J].现代生物医学进展,2012,12(19):3741-3743. 被引量:3
同被引文献19
-
1Ramos F, Baglivo HP, Ramirez AJ, et al. The metabolic syndrome and related eardlovaseulaa risk [J].Curr Hypertens Rep, 2001 3 (2) : 100-106.
-
2Donnandy JA, Charbonnel B, Eckland DJA, et al.Secondary prevention of macrovasculm events in patients with type 2 diabetes in the PRO active sutdy ( PRO speetive pioglitazone clinical trial in macruvascular events):a randomised conu-olled trial [ J ]. Larwet, 2005,366 (9493) : 1 279-289.
-
3Hanefeld M, Marx N, Pfutzner A, et al. Anti-inflammatory effects of plo-glitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the P1OSTAT Study [J]. J Am Coll Cardiol, 2007, 49 (3) : 290-297.
-
4Keech A, Simes RJ, Barter P, et al. Effects of long-term fenoflbrate ther- apy on cardiovascular events in 9795 people with type 2 diabetes menitus (the FIELD study) : randomised controlled trial[J]. Lancet, 2005, 366: 1 849-861.
-
5Nakagawa T, Hu H, ZhmSkov S, et al. A causal role for uric acid in fructose-induced metabolicc syndrome [J].Am J Physiol Renal Physiol, 2006, 290 (3) : 625-531.
-
6Rayssiguierl Y, Gueux E, Nowacki W, et al. High fiuetose consumption combined with low dietary magnesium intake may increase the incidence of the metabolic syndrome by inducing inflammation [J].Magnesium Research, 2006, 19 (4) : 237-243.
-
7Sharabi Y, Oron-Herman M, Kamafi Y, et al. Effect of PPAR-gamma agonist on adiponectin levels in the metabolic syndrome: lessons fiom the high fructose fed rat model [J].Am J Hypertens, 2007, 20 (2) : 206- 210.
-
8Peredo HA, Mayer MA, Caranza A, et al. Pioglltazone and losartan modify hemodynamic and metabolic parameters and vascular prostanoids in fiaactose-overloaded rats [J].Clin Exp Hypertens, 2008, 30 (2) : 159- 169.
-
9Orasanu G, Ziouzenkova O. Devchand PR, et aJ. The perosisone prolif- erator-actlvated receptor-gamma agomist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-alpha-dependent manner in vitxu and in vivo in mice [J].J Am CoU Cardiol, 2008, 52 (10) : 869- 881.
-
10Vosper H, Khoudoli GA, Graham TL, et al. Peroxisome proliferator-aetivated receptor agonists hyperlipidaemia, and athemsclerosis [J].Pharmacol Ther, 2002, 95 ( 1 ) : 4762.
引证文献2
-
1罗玉梅,姜德谦,万新红,刘显庆,柴湘平,郭洪波,陈朝霞.吡格列酮和非诺贝特在调节代谢综合征大鼠主动脉重构中的作用[J].中国动脉硬化杂志,2009,17(12):966-970. 被引量:5
-
2万新红,罗玉梅,郭洪波,彭惠媚,王美香,谭琼清.非诺贝特和吡格列酮干预对代谢综合征大鼠PPAR-α、PPAR-γ表达的影响[J].热带医学杂志,2013,13(9):1068-1071.
二级引证文献5
-
1万新红,罗玉梅,姜德谦,何俊峰,柴湘平,郭洪波,罗玉婵.miRNA-195、贝那普利与自发性高血压大鼠主动脉重构[J].中国动脉硬化杂志,2014,22(3):227-232. 被引量:4
-
2周健,张旭升,黄战军,樊小容,蔡博治.麝香保心丸对代谢综合征大鼠血管重构的影响[J].中国民族民间医药,2019,28(1):12-14. 被引量:1
-
3张旭升,朱平先,黄战军,蔡博治,张昕,张勇刚.代谢综合征模型大鼠主动脉尾加压素Ⅱ及其受体表达及意义[J].岭南心血管病杂志,2018,24(1):92-95. 被引量:4
-
4张旭升,黄战军,樊小容,谭小青,蔡博治,张昕.螺内酯对代谢综合征大鼠主动脉重构的作用[J].国际心血管病杂志,2019,46(2):95-98. 被引量:2
-
5廖丛娟,张旭升,黄战军,樊小容,谭小青,蔡博治.麝香保心丸下调代谢综合征大鼠心肌组织尾加压素Ⅱ及其受体表达的实验研究[J].中西医结合心脑血管病杂志,2020,18(15):2414-2417. 被引量:1
-
1易光辉.过氧化体增殖物激活型受体与脂代谢和动脉粥样硬化[J].中国动脉硬化杂志,2005,13(1):119-120. 被引量:10
-
2杨娜,丁世芳.噻唑烷二酮类药物干预动脉粥样硬化的研究进展[J].中国动脉硬化杂志,2009,17(9):783-786. 被引量:1
-
3彭道泉,赵水平,聂赛,李江.载脂蛋白E与过氧化体增殖物激活型受体-γ基因多态性的相互作用及其与冠心病的关系[J].中华心血管病杂志,2002,30(6):351-355. 被引量:29
-
4黄颖,陈运贞.过氧化体增殖物激活型受体抑制氧化型脂蛋白致血管内皮细胞凋亡[J].中国动脉硬化杂志,2004,12(4):419-422. 被引量:5
-
5徐健强,赵国军,王燕,喻思扬,曾高峰.阿托伐他汀的抗炎作用及其机制的研究进展[J].中国动脉硬化杂志,2016,24(4):419-423. 被引量:38
-
6叶平.过氧化体增殖物激活型受体在控制炎症反应中的作用[J].中国动脉硬化杂志,2002,10(3):260-262. 被引量:2
-
7陈静,叶平,刘永学,贺艳丽.亚油酸对纤溶酶原激活物抑制剂-1表达的影响及其机制[J].中华老年多器官疾病杂志,2006,5(2):124-127. 被引量:3
-
8盛莉,叶平,刘永学,韩春光.过氧化体增殖物激活型受体β/δ激活剂抑制体外血管紧张素Ⅱ诱导的心肌细胞肥大[J].中国动脉硬化杂志,2007,15(12):885-888. 被引量:2
-
9叶平.过氧化体增殖物激活型受体对心肌能量代谢调控的病理生理机制[J].中国动脉硬化杂志,2003,11(1):81-83. 被引量:5
-
10Steven E. Nissen, MD,Stephen J. Nicholls, MBBS, PhD,Kathy Wolski, MPH,Daniel C. Howey, MD,Ellen McErlean, RN, MSN,Ming-Dauh Wang, PhD,Elisa V. Gomez, MS,John M. Russo, MD,靳文英(译),顾佳(校).强效高选择性PPAR-α激动剂对致动脉粥样硬化性血脂紊乱或高胆固醇血症患者的影响—两项随机对照试验[J].美国医学会杂志(中文版),2008,27(2):76-86.